FDA Panel to Review Moderna’s Flu Vaccine for Older Adults
The U.S. Food and Drug Administration’s (FDA) independent vaccine advisory panel is set to review and vote on whether the benefits of Moderna’s influenza vaccine, mFlusiva, outweigh its potential risks in older adults. Moderna...
U.S. Hospitals on Alert as Ebola Risk During World Cup Remains Low
Public health experts say the risk of an Ebola-infected traveler arriving in the United States during the 2026 FIFA World Cup is low, but not impossible. With millions of fans expected to travel across...
Some U.S. Employers Plan to End Coverage of Weight-Loss Drugs as Costs Continue to Rise
Large employers in the United States are increasingly reconsidering coverage for GLP-1 weight-loss medications such as Wegovy, Zepbound, and Foundayo as growing demand continues to drive healthcare costs higher. According to recent surveys, around...